← FDA DRUG APPROVALS

FDA ANDA · ANDA040525

PHENTERMINE HYDROCHLORIDE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA040525
TYPE
ANDA
ORIGINAL APPROVAL
2003-10-23
LATEST ACTION
2017-05-31
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PHENTERMINE HYDROCHLORIDEDiscontinued
PHENTERMINE HYDROCHLORIDE 30MG · CAPSULE · ORAL

Approval history

2017-05-31Labeling · Supplement 17 · standardAP
2012-12-06Labeling · Supplement 11 · standardAP
2012-12-06Labeling · Supplement 12 · standardAP
2003-10-23OriginalAP
2003-10-23UNKNOWN · Supplement 1 · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →